Literature DB >> 8596571

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

P G McGovern1, J S Pankow, E Shahar, K M Doliszny, A R Folsom, H Blackburn, R V Luepker.   

Abstract

BACKGROUND: Mortality from coronary heart disease (CHD) has declined in the United States since the late 1960s. To understand the reasons for the decline during the period form 1985 to 1990, we examined trends in mortality and morbidity due to CHD, medical care, and risk factors for CHD in a large metropolitan population.
METHODS: We identified all deaths from CHD in residents of the Minneapolis-St. Paul, Minnesota, metropolitan area who were 30 to 74 years old and classified the deaths according to whether they occurred in or out of the hospital. For 1985 and 1990, we obtained lists of patients in this age range who were discharged with a diagnosis of acute CHD from all area hospitals, and we selected the medical records of 50 percent of these patients for abstraction. Definite myocardial infarctions were identified with standardized diagnostic algorithm. The 1985 and 1990 cohorts of patients hospitalized for myocardial infarction were followed for at least three years to identify those who died from any cause. Trends in risk factors for CHD were investigated through surveys of 25-to-74-year-olds that were conducted in 1985 through 1987 and 1990 through 1992.
RESULTS: Between 1985 and 1990, mortality from CHD fell by 25 percent for both men and women, and the decline in in-hospital mortality (41 percent) exceeded the decline in out-of-hospital mortality (17 percent) among men. The rates of hospitalization for acute myocardial infarction declined slightly, by 5 to 10 percent, between 1985 and 1990. Survival among patients hospitalized for acute myocardial infarction increased substantially during that period. After adjustment for age and previous myocardial infarction, the relative risk of dying within three years of hospitalization for a myocardial infarction (for the 1990 cohort as compared with the 1985 cohort) was 0.76 for men (95 percent confidence interval, 0.65 to 0.89) and 0.84 for women (95 percent confidence interval, 0.71 to 1.00). Substantial increases in the use of thrombolytic therapy, heparin, aspirin, and coronary angioplasty paralleled the survival trends. In general, the risk-factor profile of the area population with respect to CHD also improved considerably during that time.
CONCLUSIONS: The recent decline in mortality due to CHD in the Minneapolis-St. Paul metropolitan area can be explained by both the declining incidence of myocardial infarction in the population and the improved survival of patients with myocardial infarction.

Entities:  

Mesh:

Year:  1996        PMID: 8596571     DOI: 10.1056/NEJM199604043341403

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  103 in total

Review 1.  Impact of treatment of sleep apnoea on left ventricular function in congestive heart failure.

Authors:  M T Naughton
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

2.  Trends in cardiovascular risk factor levels in the Minnesota Heart Survey (1980-2002) as compared with the National Health and Nutrition Examination Survey (1976-2002): A partial explanation for Minnesota's low cardiovascular disease mortality?

Authors:  Huifen Wang; Lyn M Steffen; David R Jacobs; Xia Zhou; Henry Blackburn; Alan K Berger; Kristian B Filion; Russell V Luepker
Journal:  Am J Epidemiol       Date:  2011-01-27       Impact factor: 4.897

3.  Effects of emotional and physiological stress on plaque instability in apolipoprotein E knockout mice.

Authors:  Tao Zhang; Yongzhi Zhai; Yundai Chen; Zhenhong Zhou; Junjie Yang; Hongbin Liu
Journal:  J Physiol Biochem       Date:  2011-04-22       Impact factor: 4.158

4.  Screening for coronary heart disease: cardiology through the oncology looking glass.

Authors:  D Douglas Miller; Leslee J Shaw
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

5.  Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.

Authors:  Julie C Lauffenburger; Jennifer G Robinson; Christine Oramasionwu; Gang Fang
Journal:  Circulation       Date:  2013-12-10       Impact factor: 29.690

6.  Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study.

Authors:  Nisha I Parikh; Philimon Gona; Martin G Larson; Caroline S Fox; Emelia J Benjamin; Joanne M Murabito; Christopher J O'Donnell; Ramachandran S Vasan; Daniel Levy
Journal:  Circulation       Date:  2009-02-23       Impact factor: 29.690

7.  Trends in Incidence of Hospitalized Acute Myocardial Infarction in the Cardiovascular Research Network (CVRN).

Authors:  Kristi Reynolds; Alan S Go; Thomas K Leong; Denise M Boudreau; Andrea E Cassidy-Bushrow; Stephen P Fortmann; Robert J Goldberg; Jerry H Gurwitz; David J Magid; Karen L Margolis; Catherine J McNeal; Katherine M Newton; Rachel Novotny; Charles P Quesenberry; Wayne D Rosamond; David H Smith; Jeffrey J VanWormer; Suma Vupputuri; Stephen C Waring; Marc S Williams; Stephen Sidney
Journal:  Am J Med       Date:  2016-10-14       Impact factor: 4.965

8.  Added value of a resting ECG neural network that predicts cardiovascular mortality.

Authors:  Marco V Perez; Frederick E Dewey; Swee Y Tan; Jonathan Myers; Victor F Froelicher
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-01       Impact factor: 1.468

9.  Coronary artery diseases in South Asian immigrants: an update on high density lipoprotein role in disease prevention.

Authors:  Sunita Dodani
Journal:  J Immigr Minor Health       Date:  2008-09-24

10.  All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984-1997.

Authors:  Kyle Steenland; Sherry Hu; James Walker
Journal:  Am J Public Health       Date:  2004-06       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.